Bergh · Fertility and sterility 1993 · in vitro experimental cell culture study · n=8

Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.

Cited 252 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro laboratory study using excised human ovarian tissue (bench research)

PubMed 8425626 · doi:10.1016/s0015-0282(16)55675-1 · record verified 2026-08-27

What was done

Fresh theca interna tissue and dispersed thecal cells were isolated from the leading ovarian follicles of 8 women in the follicular phase undergoing gynecological laparotomy for non-ovarian indications. Poly-adenine+ RNA was analyzed by Northern blot for insulin and IGF-I receptor transcripts. Thecal cells were cultured for 4 to 6 days with or without luteinizing hormone (LH), IGF-I, and insulin, and medium concentrations of androstenedione and testosterone were quantified by radioimmunoassay.

What was found

Both IGF-I receptor and insulin receptor transcripts were detected in separated human thecal tissue. In culture, IGF-I and insulin potentiated LH-stimulated secretion of androstenedione and testosterone, while exerting less pronounced effects on basal androgen production. The abstract reports no numerical values, hormone concentrations, or statistical significance metrics.

Why it matters

This study provides direct in vitro evidence that human thecal cells express insulin and IGF-I receptors and that both peptides synergize with LH to amplify androgen production. These findings help explain the pathophysiological link between hyperinsulinemia and ovarian hyperandrogenism.

Limits

The study is an in vitro bench experiment with a small sample size of 8 women and provides no quantitative data or p-values in the abstract. Tissues were obtained only from normal follicular-phase leading follicles, limiting direct extrapolation to in vivo physiology or polycystic ovary pathology.

Cited by